Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/8911
Title: Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology databases to evaluate AIDS (IeDEA) consortium, 2016–2017 and 2020
Authors: Parcesepe, Angela M.
Stockton, Melissa
Remch, Molly
Weste, C. William
Bernard, Charlotte
Ross, Jeremy
Haas, Andreas D.
Ajeh, Rogers
Althoff, Keri N.
Enane, Leslie
Pape, William
Minga, Albert
Kwobah, Edith
Tlali, Mpho
Tanuma, Junko
Nsonde, Dominique
Freeman, Aimee
Duda, Stephany N.
Nash, Denis
Lancaster, Kathryn
Keywords: Mental health
HIV
Integration
Depression
Anxiety
PTSD
Issue Date: 17-Jul-2023
Publisher: John Wiley & Sons Ltd.
Abstract: Introduction: Common mental disorders (CMDs) are highly prevalent among people with HIV. Integrating mental healthcare into HIV care may improve mental health and HIV treatment outcomes. We describe the reported availability of screening and treatment for depression, anxiety and post-traumatic stress disorder (PTSD) at global HIV treatment centres participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium in 2020 and changes in availability at sites in low- or middle-income countries (LMICs) between 2016/2017 and 2020. Methods: In 2020, 238 sites contributing individual-level data to the IeDEA Consortium and in 2016/2017 a stratified ran- dom sample of IeDEA sites in LMICs were eligible to participate in site surveys on the availability of screening and treatment for CMDs. We assessed trends over time for 68 sites across 27 LMICs that participated in both surveys. Results: Among the 238 sites eligible to participate in the 2020 site survey, 227 (95%) participated, and mental health screen- ing and treatment data were available for 223 (98%) sites across 41 countries. A total of 95 sites across 29 LMICs completed the 2016/2017 survey. In 2020, 68% of sites were in urban settings, and 77% were in LMICs. Overall, 50%, 14% and 12% of sites reported screening with a validated instrument for depression, anxiety and PTSD, respectively. Screening plus treatment in the form of counselling was available for depression, anxiety and PTSD at 46%, 13% and 11% of sites, respectively. Screen- ing plus treatment in the form of medication was available for depression, anxiety and PTSD at 36%, 11% and 8% of sites, respectively. Among sites that participated in both surveys, screening for depression was more commonly available in 2020 than 2016/2017 (75% vs. 59%, respectively, p = 0.048). Conclusions: Reported availability of screening for depression increased among this group of IeDEA sites in LMICs between 2016/2017 and 2020. However, substantial gaps persist in the availability of mental healthcare at HIV treatment sites across global settings, particularly in resource-constrained settings. Implementation of sustainable strategies to integrate mental health services into HIV care is needed.
URI: http://onlinelibrary.wiley.com/doi/10.1002/jia2.26147/full
http://ir.mu.ac.ke:8080/jspui/handle/123456789/8911
Appears in Collections:School of Medicine

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.